Novartis Investigative Site

Saint Priest En Jarez, Pays de la Loire Region 42270

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Chronic Myelogenous Leukemia, Myelogenous Leukemia, Chronic

Studies at this site

• Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients — Completed
• A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) — Completed
• Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor — Completed